A comparison between ultrasonography and mammography, computed tomography and digital subtraction angiography for the detection of breast cancers

Abstract

Ultrasound (US) was compared with mammography (MMG), computed tomography (CT), and digital subtraction angiography (DSA) in its effectiveness to detect breast cancer masses and metastatic axillary nodes. Forty-seven breast cancer patients who all underwent MMG, US, CT, and DSA preoperatively in our institution between 1986 and 1990 were studied. US was able to detect tumors in all cases regardless of tumor size, whereas DSA detected T1-size tumors and MMG detected T2-size tumors in 40% and 64.7% of cases, respectively, being specifically inferior to US. It was found that MMG was least likely to detect papillotubular carcinoma, although microcalcification alone without a tumor mass on MMG improved detectability from 46.2% to 76.9%, according to the histological type. CT was found to be most sensitive to axillary node metastases (81.8%), followed by US (72.7%), but DSA was significantly unfavorable (42.9%). Thus, we concluded that US was superior to MMG, CT, and DSA for detecting breast cancer masses, but that CT was more advantageous than US, while DSA was of little value for evaluating axillary nodal status.

Ultrasonographic and Mammographic Evaluation of Breast Lesions

“…Ultrasound is an excellent imaging method to evaluate the various breast lesions when compared to mammography. (Table 5) [10] 100% 64.7% Nasu et al [11] 88.76% 84.27% Sachin Prasad et al [3] 70% 77%…”

Detection of incidental breast tumors by noncontrast spiral computed tomography of the chest

“…Several recent reports have described the usefulness of low-dose spiral chest CT for visualizing lesions in the lung, and a few reports have emphasized that breast abnormalities can also be identifi ed by CT. [7][8][9] Because CT is sometimes the fi rst radiological study to detect early breast cancer in asymptomatic women, it is important to be familiar with the CT appearance of this disease. 7,8 A small number of authors have stressed the usefulness of noncontrast chest CT for detecting breast tumors, 9,10 and many have recommended contrast-enhanced CT for detection of breast cancer. 7,[11][12][13][14][15] We conducted a 3-year clinical study to evaluate the detection rate of abnormal breast lesions, including breast cancer, by noncontrast spiral chest CT as well as the appearance of these lesions on the CT scans.…”

Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy

“…There is extensive literature on the use of these three modalities in measuring breast primary tumors and the extent of residual disease after chemotherapy [4,[10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27]. However, we found no study to prospectively evaluate the ability of imaging to predict pathologic CR following neoadjuvant chemotherapy.…”